Evaluating Online Messages About Colon Cancer Screening

September 25, 2025 updated by: University of Utah
The goal of the study is to determine, using a choice-based approach, what messages (pulled from various online sites) people find more and less persuasive and shareable on the topic of colorectal cancer screening. As a secondary goal, the study is interested how various information behaviors, such as people's self-reported seeking of health information and encountering of health information, demographic variables, individual difference variables, and message exposure associate with their intentions to adhere to recommended colorectal cancer screening guidelines from the National Cancer Institute. The study is interested at differences specifically among Black and White Americans of recommended screening age (45-74).

Study Overview

Study Type

Observational

Enrollment (Actual)

2210

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Utah
      • Salt Lake City, Utah, United States, 84112
        • University of Utah Hospital/ Huntsman Cancer Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Participants will be White (n=1,000) and Black (n=1,000) Americans between the ages of 45 and 74. The goal of the study is to determine if there are differences in message preferences and evaluations between these two groups due to historical disparities in colorectal cancer screening uptake and outcomes.

Description

Inclusion Criteria:

  • Identify as white/Caucasian or Black/African American.

Exclusion Criteria:

  • Do not identify as white/Caucasian or Black/African American.
  • Previously diagnosed with colorectal cancer

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Perceived Shareablility Prompt First

Participants will assess pairs of messages with the prompt, "Which of the messages below is more likely to make you want to get screened for colorectal cancer?

Participants will also be able to provide their own idea for a message rather than selecting a message from the pairs presented.

Participants will assess pairs of messages with the prompt, "Which of the messages below would you be more likely to share with your friends or family?"

Participants will also be able to provide their own idea for a message rather than selecting a message from the pairs presented.

Perceived Effectiveness Prompt First

Participants will assess pairs of messages with the prompt, "Which of the messages below is more likely to make you want to get screened for colorectal cancer?

Participants will also be able to provide their own idea for a message rather than selecting a message from the pairs presented.

Participants will assess pairs of messages with the prompt, "Which of the messages below would you be more likely to share with your friends or family?"

Participants will also be able to provide their own idea for a message rather than selecting a message from the pairs presented.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants in Determining Messages
Time Frame: 15 minutes
This outcome measure will report the number of participants who participated in determining the Online Messages About Colon Cancer Screening. This study will help determine the content of Colon Cancer Screening messaging for future research.
15 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intentions to Follow Screening Recommendations in the Future
Time Frame: 15 minutes
Single item self-report of intentions to follow USPSTF recommendations for colorectal cancer screening on a seven-point scale. A low score (Minimum: 1 Extremely Unlikely to follow USPSTF recommendations) is an unfavorable outcome and a high score (Maximum: 7 Extremely Likely to follow USPSTF recommendations) is a favorable outcome.
15 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Andy J. King, PhD, Huntsman Cancer Institute/ University of Utah

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 5, 2023

Primary Completion (Actual)

February 8, 2024

Study Completion (Actual)

February 8, 2024

Study Registration Dates

First Submitted

November 10, 2023

First Submitted That Met QC Criteria

November 10, 2023

First Posted (Actual)

November 18, 2023

Study Record Updates

Last Update Posted (Actual)

October 20, 2025

Last Update Submitted That Met QC Criteria

September 25, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colonic Cancer

Clinical Trials on Perceived Effectiveness Prompt

Subscribe